tiprankstipranks
Trending News
More News >
Jazz Pharmaceuticals (DE:J7Z)
FRANKFURT:J7Z
Germany Market

Jazz Pharmaceuticals (J7Z) Ratios

Compare
3 Followers

Jazz Pharmaceuticals Ratios

DE:J7Z's free cash flow for Q4 2024 was $1.00. For the 2024 fiscal year, DE:J7Z's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.46 2.24 2.79 3.23 4.34
Quick Ratio
3.99 1.85 2.03 1.90 4.20
Cash Ratio
2.32 0.98 0.94 0.73 1.62
Solvency Ratio
0.07 0.14 0.05 0.03 0.18
Operating Cash Flow Ratio
1.34 0.71 1.36 0.96 1.38
Short-Term Operating Cash Flow Coverage
45.03 1.81 41.03 25.11 3.65
Net Current Asset Value
$ -3.29B$ -4.22B$ -5.14B$ -5.72B$ -36.59M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.51 0.53 0.50 0.34
Debt-to-Equity Ratio
0.02 1.55 1.88 1.55 0.61
Debt-to-Capital Ratio
0.02 0.61 0.65 0.61 0.38
Long-Term Debt-to-Capital Ratio
<0.01 0.58 0.65 0.60 0.34
Financial Leverage Ratio
2.93 3.05 3.51 3.10 1.79
Debt Service Coverage Ratio
3.00 1.50 2.23 2.62 1.78
Interest Coverage Ratio
3.01 2.00 1.78 0.61 7.68
Debt to Market Cap
<0.01 0.73 0.57 0.80 0.23
Interest Debt Per Share
4.98 96.08 97.29 107.48 41.90
Net Debt to EBITDA
-3.27 3.50 8.87 5.40 1.81
Profitability Margins
Gross Profit Margin
100.00%88.64%85.23%85.76%93.70%
EBIT Margin
17.41%15.32%-2.07%5.36%15.86%
EBITDA Margin
17.61%31.98%15.13%33.21%27.49%
Operating Profit Margin
17.61%15.09%14.00%5.50%32.39%
Pretax Profit Margin
11.56%7.77%-10.19%-3.65%11.64%
Net Profit Margin
13.77%10.82%-5.85%-10.63%10.10%
Continuous Operations Profit Margin
13.77%10.90%-6.12%-10.65%10.10%
Net Income Per EBT
119.09%139.24%57.44%291.53%86.74%
EBT Per EBIT
65.63%51.49%-72.77%-66.27%35.94%
Return on Assets (ROA)
4.66%3.64%-1.98%-2.67%3.65%
Return on Equity (ROE)
13.68%11.10%-6.94%-8.30%6.52%
Return on Capital Employed (ROCE)
6.53%5.87%5.17%1.48%13.01%
Return on Invested Capital (ROIC)
7.74%7.74%2.96%4.30%10.94%
Return on Tangible Assets
10.11%9.83%-6.40%-9.91%7.05%
Earnings Yield
7.36%5.33%-2.15%-4.33%2.59%
Efficiency Ratios
Receivables Turnover
5.68 5.43 5.62 5.49 5.96
Payables Turnover
0.00 4.24 5.96 4.39 5.53
Inventory Turnover
0.00 0.73 0.76 0.41 1.56
Fixed Asset Turnover
17.93 16.32 12.14 9.01 9.19
Asset Turnover
0.34 0.34 0.34 0.25 0.36
Working Capital Turnover Ratio
1.48 2.15 2.11 1.55 1.37
Cash Conversion Cycle
64.30 481.39 485.89 871.73 229.00
Days of Sales Outstanding
64.30 67.19 64.98 66.45 61.23
Days of Inventory Outstanding
0.00 500.30 482.19 888.34 233.82
Days of Payables Outstanding
0.00 86.10 61.29 83.06 66.04
Operating Cycle
64.30 567.49 547.17 954.79 295.05
Cash Flow Ratios
Operating Cash Flow Per Share
22.57 17.25 20.34 13.04 16.15
Free Cash Flow Per Share
21.80 16.88 12.37 12.28 9.34
CapEx Per Share
0.78 0.38 7.97 0.76 6.81
Free Cash Flow to Operating Cash Flow
0.97 0.98 0.61 0.94 0.58
Dividend Paid and CapEx Coverage Ratio
29.04 45.57 2.55 17.10 2.37
Capital Expenditure Coverage Ratio
29.04 45.57 2.55 17.10 2.37
Operating Cash Flow Coverage Ratio
19.96 0.19 0.22 0.13 0.40
Operating Cash Flow to Sales Ratio
0.34 0.28 0.35 0.25 0.38
Free Cash Flow Yield
17.70%13.72%7.77%9.64%5.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.60 18.77 -46.53 -23.12 38.54
Price-to-Sales (P/S) Ratio
1.87 2.03 2.72 2.46 3.89
Price-to-Book (P/B) Ratio
1.86 2.08 3.23 1.92 2.51
Price-to-Free Cash Flow (P/FCF) Ratio
5.65 7.29 12.88 10.38 17.67
Price-to-Operating Cash Flow Ratio
5.46 7.13 7.83 9.77 10.22
Price-to-Earnings Growth (PEG) Ratio
0.45 -0.06 1.23 0.10 -0.72
Price-to-Fair Value
1.86 2.08 3.23 1.92 2.51
Enterprise Value Multiple
7.36 9.84 26.87 12.80 15.97
EV to EBITDA
7.36 9.84 26.87 12.80 15.97
EV to Sales
1.30 3.15 4.07 4.25 4.39
EV to Free Cash Flow
3.91 11.30 19.23 17.94 19.93
EV to Operating Cash Flow
3.78 11.05 11.70 16.89 11.53
Tangible Book Value Per Share
-38.46 -54.26 -70.38 -84.01 9.09
Shareholders’ Equity Per Share
66.20 59.04 49.34 66.43 65.69
Tax and Other Ratios
Effective Tax Rate
-0.19 -0.40 0.43 -1.92 0.12
Revenue Per Share
65.80 60.58 58.51 51.83 42.42
Net Income Per Share
9.06 6.55 -3.42 -5.51 4.28
Tax Burden
1.19 1.39 0.57 2.92 0.87
Interest Burden
0.66 0.51 4.93 -0.68 0.73
Research & Development to Revenue
0.11 0.22 0.16 0.16 0.14
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.06 0.06 0.06 0.06 0.05
Income Quality
2.49 2.63 -5.68 -2.36 3.77
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis